CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 12/31/2014

Position Statistics

Total Positions 75
New Positions 11
Increased Positions 27
Decreased Positions 16
Positions with Activity 43
Sold Out Positions 6
Total Mkt Value (in $ millions) 702

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 16.32%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 57.03%
Services
Technology
Transportation
Utilities

16 DECREASED Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
RECEPTOS INC COM 100,378 -16,719 (14.28) 641,800
PUMA BIOTECHNOLOGY INC COM 41,417 -54,125 (56.65) 220,000
CHINA BIOLOGIC PRODS INC COM 8,838 -491 (5.26) 90,000
BIOCRYST PHARMACEUTICALS COM 7,488 -2,808 (27.27) 800,000
ACCELERON PHARMA INC COM 7,185 -4,311 (37.5) 250,000
IMMUNE DESIGN CORP COM 3,220 -1,380 (30) 140,000
AKEBIA THERAPEUTICS INC COM 926 -2,214 (70.5) 118,000
GALECTIN THERAPEUTICS INC COM NEW 920 -408 (30.73) 312,000
PTC THERAPEUTICS INC COM 599 -6,884 (92) 10,000
SAGE THERAPEUTICS INC COM 55 -492 (90) 1,000
AGIOS PHARMACEUTICALS INC COM -9,574 Sold Out 0
ALNYLAM PHARMACEUTICALS INC COM -5,345 Sold Out 0
ARROWHEAD RESH CORP COM NEW -6,273 Sold Out 0
CLOVIS ONCOLOGY INC COM -5,746 Sold Out 0
JAZZ PHARMACEUTICALS PLC SHS USD -18,074 Sold Out 0
ZS PHARMA INC COM -1,951 Sold Out 0